Summary:
Study to investigate the safety and tolerability following a single intravenous (IV) dose of investigational medication administered to ambulatory adult patients with COVID-19
Qualified Participants Must:
• Have first onset of COVID-19 symptoms less than 7 days at randomization: fever and/or chills, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomitting, diarrhea
• Positve COVID PT-PCR test within 72 hours prior to randomization
• Aged 18 years or above.
Qualified Participants May Receive:
For your time and travel, you will receive $135 for each completed clinic visit.